← Back to all trials
Not Yet Recruiting
NCT05701150
AIO-BNHO Comprehensive Clinico-genomics Database Network - AIO-BNHO CONNECT
Conditions: Advanced Solid Tumor
Sex: All
Ages: 18 Years – N/A
Enrollment: 3000
Sponsor: AIO-Studien-gGmbH
Location: Germany
Summary
National, retro- and prospective, observational, multicenter clinical research platform to connect clinical and genomic data of patients with advanced (locally advanced, inoperable, or metastatic) solid tumors (excluding NSCLC, SCLC, and mesothelioma) with results from multi-gene next-generation sequencing (NGS) panels (>30 genes)
Eligibility Criteria
Inclusion Criteria:Diagnosis of advanced (i.e., locally advanced, inoperable, or metastatic) solid tumor, ineligible for curative surgery and/or curative systemic therapyAvailable results of commercial or non-commercial RNA- and/or DNA-based multi-gene NGS panels with >30 genes analyzed; for non-commercial panels a list of all tested genes and multiple gene biomarkers (e.g., tumor mutational burden (TMB), microsatellite status) must be providedAge ≥ 18 yearsSigned and dated informed consent form (not applicable for inclusion of deceased patients)Exclusion Criteria:Diagnosis of NSCLC/SCLC (C34) or mesothelioma (C45)NGS results older than two years at the date of patient inclusion
Source: ClinicalTrials.gov (NCT05701150). StuddyBuddy aggregates publicly available trial information.
